Layoffs coming Q1 2025

[anonymous]

Hold on to your socks. It’s happening again according to reliable sources across the org.

 

[anonymous]

Hold on to your socks. It’s happening again according to reliable sources across the org.

Which sector/groups?

 

[anonymous]

Truth!

 

[anonymous]

Didn't everyone know this was happening? It's MedTech's turn.

 

[anonymous]

Didn't everyone know this was happening? It's MedTech's turn.

We are part of Medtech (Vision care & Vision Surgical) and our division had significant cuts in October 2024

 

[anonymous]

Hold on to your socks. It’s happening again according to reliable sources across the org.

If you’re the same person who told us to hang onto our hats about layoffs last August, I believe you! This time we will hang onto our socks!
Which divisions??

 

[anonymous]

Didn't everyone know this was happening? It's MedTech's turn.

These acquisitions aren't going to pay for themselves and Joaquin wants to buy himself a ride on Elon dick rocket.

 

[anonymous]

Didn't everyone know this was happening? It's MedTech's turn.

The fu@k it is! MT was hit hard last year.

 

[anonymous]

If you’re the same person who told us to hang onto our hats about layoffs last August, I believe you! This time we will hang onto our socks!
Which divisions??

Not the same person posting but it could still happen. Copy Cat.

 

[anonymous]

I understood it is going to be in R&D

 

[anonymous]

The fu@k it is! MT was hit hard last year.

100%

It’s a skeleton crew as-is

 

[anonymous]

I understood it is going to be in R&D

We just got our annual shipment of one albino mouse from Charles River. I think we’re safe!

By the way that one same mouse is used for testing toxicity on all the new exciting compounds that are coming through the pipeline.

Problem is we need a pipe before we have a pipeline and we have neither.

 

[anonymous]

We just got our annual shipment of one albino mouse from Charles River. I think we’re safe!

By the way that one same mouse is used for testing toxicity on all the new exciting compounds that are coming through the pipeline.

Problem is we need a pipe before we have a pipeline and we have neither.

Does that mouse need some truama product, we need all the sales we can get.

 

[anonymous]

with the robot ide approved, no need for so many expensive engineers in that shiny building..

 

[anonymous]

I herd it was going to hit all JNJ

 

[anonymous]

with the robot ide approved, no need for so many expensive engineers in that shiny building..

Well, the next generation of robot will be autonomous, so once Ottava is rolled out, it will be a legacy offering.
da Vinci is well ahead in that space (see links below). JNJ does not create any value organically, they sell off old assets and then buy into startups in areas that they cannot develop themselves due to all the bureaucracy and the stagnant managers that are just limping along to get to pension age. JJ Innovation (Innovation Centers | JNJ Innovation) is where all the organic R&D dollars are moving towards. Johnson and Johnson is simply a holding company of assets that they purchase with a rare occasion of an internal development.

More on autonomous surgical robots of the future.
New AI Research Foreshadows Autonomous Robotic Surgery | NVIDIA Technical Blog
Surgical Robot Transformer: Imitation Learning for Surgical Tasks

 

[anonymous]

Well, the next generation of robot will be autonomous, so once Ottava is rolled out, it will be a legacy offering.
da Vinci is well ahead in that space (see links below). JNJ does not create any value organically, they sell off old assets and then buy into startups in areas that they cannot develop themselves due to all the bureaucracy and the stagnant managers that are just limping along to get to pension age. JJ Innovation (Innovation Centers | JNJ Innovation) is where all the organic R&D dollars are moving towards. Johnson and Johnson is simply a holding company of assets that they purchase with a rare occasion of an internal development.

More on autonomous surgical robots of the future.
New AI Research Foreshadows Autonomous Robotic Surgery | NVIDIA Technical Blog
Surgical Robot Transformer: Imitation Learning for Surgical Tasks

SPOT ON!!! And then, whatever J&J buys......they will run it into the ground with kool aid drinking CREEDO douche bags from all sorts of other J&J companies that know ABSOLUTELY nothing of the new product. PEERIOD!!

 

[anonymous]

SPOT ON!!! And then, whatever J&J buys......they will run it into the ground with kool aid drinking CREEDO douche bags from all sorts of other J&J companies that know ABSOLUTELY nothing of the new product. PEERIOD!!

This. x1000.

 

[anonymous]

There were already layoffs for Ottava two weeks ago so I wouldn’t be surprised if there are more. Anyone know about the state of the Wound Closure & Healing and Biosurgery business units?

 

[anonymous]

Biosurgery is steady, safest place in JJ. Low growth but cash cow with 85% market share. Huge revenues.

Robots doing surgery? Who can you sue if the robot amputates the wrong leg or pokes your eyeball?